Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide-mediated oxidative damage is a pathological state resulting from the overproduction of superoxide anion radicals (O2•−), which causes the oxidative modification and degradation of cellular macromolecules including lipids, proteins, and nucleic acids (Oxford Academic, 2024; NIH, 2024). Superoxide is a primary reactive oxygen species (ROS) produced mainly by the mitochondrial respiratory chain and enzymes such as NADPH oxidase (NOX) and xanthine oxidase (NIH, 2024; University of Cambridge, 2026). While superoxide serves as a signaling molecule at physiological levels, its excessive accumulation leads to oxidative stress, contributing to the progression of various conditions such as neurodegenerative diseases, cardiovascular disorders, and ischemia-reperfusion injury (University of Cambridge, 2026; ResearchGate, 2026). Therapeutic strategies to mitigate this damage focus on enhancing antioxidant defenses through superoxide dismutase (SOD) mimetics or by inhibiting the enzymatic sources of superoxide production (ResearchGate, 2026; MDPI, 2024). The damage often involves the inactivation of iron-sulfur cluster-containing enzymes and the initiation of lipid peroxidation cascades (Oxford Academic, 2024; MDPI, 2024). Furthermore, superoxide can react with nitric oxide to form peroxynitrite, a highly reactive nitrogen species that further exacerbates cellular injury (NIH, 2024; MDPI, 2024). Despite the clear role of superoxide in disease, many antioxidant trials have failed, highlighting the need for more targeted approaches that do not interfere with essential signaling pathways (University of Cambridge, 2026; ResearchGate, 2026).
Neutralization of superoxide radicals through dismutation mimetics or inhibition of superoxide-generating enzymes like NADPH oxidase.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide-mediated oxidative damage.